Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations

• Published in: Cell and tissue banking 2018-12, Vol.19 (4), p.681-695
• Main Authors: Padalko, Elizaveta, Lagrou, Katrien, Delforge, Marie-Luce, Jansens, Hilde, Ectors, Nadine, Pirnay, Jean-Paul, Klykens, Johan, Sokal, Etienne, Muylle, Ludo, Libois, Agnes, Vanderkelen, Alain, Verbeken, Gilbert, Matthys, Conny, Goossens, Dominique, Hanssens, Geert, Baltes, Muriel, Beele, Hilde
• Format: Article
• Language: English
• Subjects: Antibodies, Viral - immunology; Belgium; Biological Assay - methods; Biomedical and Life Sciences; Biomedicine; Cell Biology; Epstein-Barr virus; Graft rejection; Hepatitis; Hepatitis B; Hepatitis C; HIV; Human Body; Human immunodeficiency virus; Humans; Legislation; Leukemia; Life Sciences; Lymphocytes; Lymphocytes T; Occupational health; Organs; RNA, Viral - analysis; Serological tests; Serology; Serum - metabolism; Syphilis; Syphilis - blood; Syphilis - diagnosis; Tissue Donors; Transplant Surgery; Transplantation; Virus Diseases - blood; Virus Diseases - diagnosis
• ISSN: 1389-9333; 1573-6814
• DOI: 10.1007/s10561-018-9721-2

This paper on the biological tests carried out on serum/plasma samples from donors of human body material (HBM) is the result of a project of the working Group of Superior Health Council of Belgium formed with experts in the field of HBM and infectious serology. Indeed, uncertainty about the interpretation of biological test results currently leads to the sometimes unjustified cancelling of planned donations or the rejection of harvested HBM, whilst more sophisticated diagnostic algorithms would still allow the use of organs or HBM that would otherwise have been rejected. NAT tests will not be discussed in this publication. In the first part some general aspects as the need for a formal agreement between the Tissue Establishment l and the laboratory responsible for the biological testing, but also some specifications regarding testing material, the choice of additional biological tests, and some general aspects concerning interpretation and reporting are discussed. In a second part, detailed information and recommendations concerning the interpretation are presented for each of the mandatory tests (human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis) is presented. A number of not mandatory, but regularly used optional serological tests (e.g. for the detection of antibodies to Toxoplasma gondii , Epstein–Barr virus, human T cell leukemia virus and cytomegalovirus) are also extensively discussed. Although the project was meant to provide clarification and recommendations concerning the Belgian legislation, the majority of recommendations are also applicable to testing of donors of tissues and cells in other (European) countries.